Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D R Mishell

Showing results (251-260 of 299) with videos related to

Pageof 30
Sort By:
Contraception|September 11, 1975
Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administrationF Z Stanczyk, M Hiroi, U Goebelsmann, et al.
Contraception|December 1, 1978
A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroidsF Z Stanczyk, P F Brenner, D R Mishell, et al.
American Journal of Obstetrics and Gynecology|October 1, 1979
The intrauterine contraceptive device and acute salpingitis: a multifactor analysisG Flesh, J M Weiner, R C Corlett, et al.
Advances in the Biosciences|January 1, 1973
Abortifacient activity of vaginally administered prostaglandin F2alphaR C Corlett, B Sribyatta, I H Thorneycroft, et al.
Steroids|September 11, 1975
Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administrationM Hiroi, F Z Stanczyk, U Goebelsmann, et al.
American Journal of Obstetrics and Gynecology|April 1, 1984
Long-term reversible contraception with levonorgestrel-releasing Silastic rodsS Roy, D R Mishell, D N Robertson, et al.
American Journal of Obstetrics and Gynecology|December 1, 1990
Antiprogestin treatment decreases midluteal luteinizing hormone pulse amplitude and primarily exerts a pituitary inhibitionD Shoupe, D R Mishell, G Fossum, et al.
American Journal of Obstetrics and Gynecology|December 1, 1987
Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phaseD Shoupe, D R Mishell, P Lahteenmaki, et al.
Prostaglandins|December 1, 1972
Termination of early gestation with vaginal prostaglandin F2 alpha tabletsR C Corlett, B Sribyatta, D R Mishell, et al.
American Journal of Obstetrics and Gynecology|December 1, 1987
Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phaseD Shoupe, D R Mishell, M A Page, et al.
Pageof 30

Showing results (251-260 of 299) with videos related to

Sort By:
Pageof 30
Contraception|September 11, 1975
Radioimmunoassay of serum d-norgestrel in women following oral and intravaginal administrationF Z Stanczyk, M Hiroi, U Goebelsmann, et al.
Contraception|December 1, 1978
A radioimmunoassay for norethindrone (NET): measurement of serum NET concentrations following ingestion of NET-containing oral contraceptive steroidsF Z Stanczyk, P F Brenner, D R Mishell, et al.
American Journal of Obstetrics and Gynecology|October 1, 1979
The intrauterine contraceptive device and acute salpingitis: a multifactor analysisG Flesh, J M Weiner, R C Corlett, et al.
Advances in the Biosciences|January 1, 1973
Abortifacient activity of vaginally administered prostaglandin F2alphaR C Corlett, B Sribyatta, I H Thorneycroft, et al.
Steroids|September 11, 1975
Radioimmunoassay of serum medroxyprogesterone acetate (Provera) in women following oral and intravaginal administrationM Hiroi, F Z Stanczyk, U Goebelsmann, et al.
American Journal of Obstetrics and Gynecology|April 1, 1984
Long-term reversible contraception with levonorgestrel-releasing Silastic rodsS Roy, D R Mishell, D N Robertson, et al.
American Journal of Obstetrics and Gynecology|December 1, 1990
Antiprogestin treatment decreases midluteal luteinizing hormone pulse amplitude and primarily exerts a pituitary inhibitionD Shoupe, D R Mishell, G Fossum, et al.
American Journal of Obstetrics and Gynecology|December 1, 1987
Effects of the antiprogesterone RU 486 in normal women. I. Single-dose administration in the midluteal phaseD Shoupe, D R Mishell, P Lahteenmaki, et al.
Prostaglandins|December 1, 1972
Termination of early gestation with vaginal prostaglandin F2 alpha tabletsR C Corlett, B Sribyatta, D R Mishell, et al.
American Journal of Obstetrics and Gynecology|December 1, 1987
Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phaseD Shoupe, D R Mishell, M A Page, et al.
Pageof 30